{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ROS", "butein", "osteosarcoma", "p53", "senescence"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33325610", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "27"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "12", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1002/tox.23079"], "Journal": {"ISSN": "1522-7278", "JournalIssue": {"Volume": "36", "Issue": "5", "PubDate": {"Year": "2021", "Month": "May"}}, "Title": "Environmental toxicology", "ISOAbbreviation": "Environ Toxicol"}, "ArticleTitle": "Butein induces cellular senescence through reactive oxygen species-mediated p53 activation in osteosarcoma U-2 OS cells.", "Pagination": {"StartPage": "773", "EndPage": "781", "MedlinePgn": "773-781"}, "Abstract": {"AbstractText": ["Butein is a flavonoid isolated from various medicinal plants. It is known to have different biological activities including anti-inflammation, anti-adipogenesis, and anti-angiogenesis. In the study, we demonstrated the anti-proliferative effect of butein in human osteosarcoma U-2 OS cells. Our data showed that butein significantly suppressed the viability and colony formation ability of U-2 OS cells. Further experiments revealed butein exposure resulted in a cell cycle arrest at S and G2/M phase in U-2 OS cells. Importantly, we found that butein activated the tumor suppressor p53, and trigged a p53-dependent senescence in U-2 OS cells. Knockdown of p53 suppressed the senescence and rescued the viability in butein-treated U-2 OS cells. Furthermore, we observed that butein exposure significantly enhanced reactive oxygen species (ROS) levels in U-2 OS cells. Co-administration of the ROS inhibitor NAC largely abolished the up-regulated p53 protein level, and rescued the suppressed viability and colony formation ability in butein-exposed U-2 OS cells. Taken together, our data proposed the increased ROS by butein exposure activated p53, and the activated p53 was involved in the anti-proliferative effect of butein via inducing senescence in U-2 OS cells. This report suggests that butein is a promising candidate for cancer therapy against osteosarcoma."], "CopyrightInformation": "\u00a9 2020 Wiley Periodicals LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, Changhua Christian Hospital, Changhua, Taiwan."}], "LastName": "Hsu", "ForeName": "Yung-Ken", "Initials": "YK"}, {"Identifier": ["0000-0002-0220-5638"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Orthopedics and Sports Medicine Laboratory, Changhua Christian Hospital, Changhua, Taiwan."}], "LastName": "Chen", "ForeName": "Hsuan-Ying", "Initials": "HY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, Changhua Christian Hospital, Changhua, Taiwan."}, {"Identifier": [], "Affiliation": "School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan."}], "LastName": "Wu", "ForeName": "Chia-Chieh", "Initials": "CC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Research, Changhua Christian Hospital, Changhua, Taiwan."}], "LastName": "Huang", "ForeName": "Ying-Chih", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, Changhua Christian Hospital, Changhua, Taiwan."}, {"Identifier": [], "Affiliation": "Orthopedics and Sports Medicine Laboratory, Changhua Christian Hospital, Changhua, Taiwan."}], "LastName": "Hsieh", "ForeName": "Cheng-Pu", "Initials": "CP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, Changhua Christian Hospital, Changhua, Taiwan."}], "LastName": "Su", "ForeName": "Po-Feng", "Initials": "PF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Orthopedics and Sports Medicine Laboratory, Changhua Christian Hospital, Changhua, Taiwan."}], "LastName": "Huang", "ForeName": "Yi-Fu", "Initials": "YF"}], "GrantList": [{"GrantID": "109-CCH-IRP-066", "Agency": "Changhua Christian Hospital Research Foundation, Changhua City, Taiwan", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Environ Toxicol", "NlmUniqueID": "100885357", "ISSNLinking": "1520-4081"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Protein p53"}, {"RegistryNumber": "4WVS5M0LGF", "NameOfSubstance": "butein"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Bone Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cellular Senescence"}, {"QualifierName": [], "DescriptorName": "Chalcones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "Osteosarcoma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["genetics"], "DescriptorName": "Tumor Suppressor Protein p53"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614-636."}, {"Citation": "Schmitt CA, Fridman JS, Yang M, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 2002;109(3):335-346."}, {"Citation": "Mooi WJ, Peeper DS. Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med. 2006;355(10):1037-1046."}, {"Citation": "Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92(20):9363-9367."}, {"Citation": "Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4(12):1798-1806."}, {"Citation": "Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest. 2018;128(4):1238-1246."}, {"Citation": "Cheng ZJ, Kuo SC, Chan SC, Ko FN, Teng CM. Antioxidant properties of butein isolated from Dalbergia odorifera. Biochim Biophys Acta. 1998;1392(2-3):291-299."}, {"Citation": "Lee JC, Lee KY, Kim J, et al. Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem Toxicol. 2004;42(9):1383-1388."}, {"Citation": "Abdallah BM, Ali EM. Butein promotes lineage commitment of bone marrow-derived stem cells into osteoblasts via modulating ERK1/2 signaling pathways. Molecules. 2020;25(8)."}, {"Citation": "Chung CH, Chang CH, Chen SS, et al. Butein inhibits angiogenesis of human endothelial progenitor cells via the translation dependent signaling pathway. Evid Based Complement Alternat Med. 2013;2013:943187."}, {"Citation": "Yang J, Sung J, Kim Y, Jeong HS, Lee J. Inhibitory effects of Butein on Adipogenesis through Upregulation of the Nrf2/HO-1 pathway in 3T3-L1 adipocytes. Prev Nutr Food Sci. 2017;22(4):306-311."}, {"Citation": "Khan N, Adhami VM, Afaq F, Mukhtar H. Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo. Antioxid Redox Signal. 2012;16(11):1195-1204."}, {"Citation": "Yang LH, Ho YJ, Lin JF, Yeh CW, Kao SH, Hsu LS. Butein inhibits the proliferation of breast cancer cells through generation of reactive oxygen species and modulation of ERK and p38 activities. Mol Med Rep. 2012;6(5):1126-1132."}, {"Citation": "Jeong GS, Lee DS, Song MY, et al. Butein from Rhus verniciflua protects pancreatic beta cells against cytokine-induced toxicity mediated by inhibition of nitric oxide formation. Biol Pharm Bull. 2011;34(1):97-102."}, {"Citation": "Kang DG, Lee AS, Mun YJ, et al. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull. 2004;27(3):366-370."}, {"Citation": "Alshammari GM, Balakrishnan A, Chinnasamy T. Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats. Biofactors. 2018;44(3):289-298."}, {"Citation": "Kim SY, Park EJ, Zhao YZ, Sohn DH. Butein suppresses bile acid-induced hepatocyte apoptosis through a JNK-dependent but ERK-independent pathway. Planta Med. 2007;73(8):777-781."}, {"Citation": "Sung B, Cho SG, Liu M, Aggarwal BB. Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling. Int J Cancer. 2011;129(9):2062-2072."}, {"Citation": "Jeong JH, An JH, Yang H, et al. Protective effect of Rhus verniciflua Stokes extract in an experimental model of post-menopausal osteoporosis. Anat Cell Biol. 2017;50(3):219-229."}, {"Citation": "Sun HH, Chen XY, Cui JQ, Zhou ZM, Guo KJ. Prognostic factors to survival of patients with chondroblastic osteosarcoma. Medicine (Baltimore). 2018;97(39):e12636."}, {"Citation": "Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115(7):1531-1543."}, {"Citation": "Moreno F, Cacciavillano W, Cipolla M, et al. Childhood osteosarcoma: incidence and survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA network 2000-2013. Pediatr Blood Cancer. 2017;64(10):e26533."}, {"Citation": "Faisham WI, Mat Saad AZ, Alsaigh LN, et al. Prognostic factors and survival rate of osteosarcoma: a single-institution study. Asia Pac J Clin Oncol. 2017;13(2):e104-e110."}, {"Citation": "Pruksakorn D, Phanphaisarn A, Arpornchayanon O, Uttamo N, Leerapun T, Settakorn J. Survival rate and prognostic factors of conventional osteosarcoma in northern Thailand: a series from Chiang Mai University Hospital. Cancer Epidemiol. 2015;39(6):956-963."}, {"Citation": "Huang YF, Chang MD, Shieh SY. TTK/hMps1 mediates the p53-dependent postmitotic checkpoint by phosphorylating p53 at Thr18. Mol Cell Biol. 2009;29(11):2935-2944."}, {"Citation": "Lin YC, Chen HY, Hsieh CP, Huang YF, Chang IL. Betulin inhibits mTOR and induces autophagy to promote apoptosis in human osteosarcoma cell lines. Environ Toxicol. 2020;35(8):879-887."}, {"Citation": "Hsu CT, Huang YF, Hsieh CP, Wu CC, Shen TS. JNK inactivation induces polyploidy and drug-resistance in Coronarin D-treated osteosarcoma cells. Molecules. 2018;23(9)."}, {"Citation": "Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315-2319."}, {"Citation": "Artandi SE, Attardi LD. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun. 2005;331(3):881-890."}, {"Citation": "Zhou Y, Wang K, Zhou N, Huang T, Zhu J, Li J. Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination. Onco Targets Ther. 2018;11:2007-2015."}, {"Citation": "Di S, Fan C, Ma Z, et al. PERK/eIF-2alpha/CHOP pathway dependent ROS generation mediates Butein-induced non-small-cell lung cancer apoptosis and G2/M phase arrest. Int J Biol Sci. 2019;15(8):1637-1653."}, {"Citation": "Bai X, Ma Y, Zhang G. Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway. Oncol Rep. 2015;33(6):3085-3092."}, {"Citation": "Moon DO, Kim MO, Choi YH, Hyun JW, Chang WY, Kim GY. Butein induces G(2)/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett. 2010;288(2):204-213."}, {"Citation": "Padmavathi G, Rathnakaram SR, Monisha J, Bordoloi D, Roy NK, Kunnumakkara AB. Potential of butein, a tetrahydroxychalcone to obliterate cancer. Phytomedicine. 2015;22(13):1163-1171."}, {"Citation": "Zhou Y, Li M, Yu X, et al. Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity. Int J Biol Sci. 2018;14(11):1521-1534."}, {"Citation": "Liao W, Liu J, Zhang D, Huang W, Chen R. Butein inhibited in vitro Hexokinase-2-mediated tumor glycolysis in hepatocellular carcinoma by blocking epidermal growth factor receptor (EGFR). Med Sci Monit. 2018;24:3283-3292."}, {"Citation": "Ma CY, Ji WT, Chueh FS, et al. Butein inhibits the migration and invasion of SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK, JNK, p38, and uPA signaling multiple pathways. J Agric Food Chem. 2011;59(16):9032-9038."}, {"Citation": "Moon DO, Choi YH, Moon SK, Kim WJ, Kim GY. Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells. Toxicol in Vitro. 2010;24(7):1927-1934."}, {"Citation": "Mandinova A, Lee SW. The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci Transl Med. 2011;3(64):64rv61."}, {"Citation": "Wesierska-Gadek J. Targeting p53 as a promising therapeutic option for cancer by re-activating the wt or mutant p53's tumor suppression. Future Med Chem. 2018;10(7):755-777."}, {"Citation": "Chen YH, Yeh CW, Lo HC, Su SL, Hseu YC, Hsu LS. Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cells. Oncol Rep. 2012;27(4):1233-1237."}, {"Citation": "Jang JH, Yang ES, Min KJ, Kwon TK. Inhibitory effect of butein on tumor necrosis factor-alpha-induced expression of cell adhesion molecules in human lung epithelial cells via inhibition of reactive oxygen species generation, NF-kappaB activation and Akt phosphorylation. Int J Mol Med. 2012;30(6):1357-1364."}, {"Citation": "Seo WY, Youn GS, Choi SY, Park J. Butein, a tetrahydroxychalcone, suppresses pro-inflammatory responses in HaCaT keratinocytes. BMB Rep. 2015;48(9):495-500."}, {"Citation": "Nam TG, Lee BH, Choi HK, Mansur AR, Lee SG, Kim DO. Rhus verniciflua Stokes extract and its flavonoids protect PC-12 cells against H2O2-induced cytotoxicity. J Microbiol Biotechnol. 2017;27(6):1090-1097."}, {"Citation": "Jung CH, Jun CY, Lee S, Park CH, Cho K, Ko SG. Rhus verniciflua stokes extract: radical scavenging activities and protective effects on H2O2-induced cytotoxicity in macrophage RAW 264.7 cell lines. Biol Pharm Bull. 2006;29(8):1603-1607."}, {"Citation": "Szuster-Ciesielska A, Mizerska-Dudka M, Daniluk J, Kandefer-Szerszen M. Butein inhibits ethanol-induced activation of liver stellate cells through TGF-beta, NFkappaB, p38, and JNK signaling pathways and inhibition of oxidative stress. J Gastroenterol. 2013;48(2):222-237."}, {"Citation": "Huang YT, Lin CI, Chien PH, Tang TT, Lin J, Chao JI. The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer. Chem Biol Interact. 2014;220:41-50."}, {"Citation": "Li Y, Ma C, Qian M, Wen Z, Jing H, Qian D. Butein induces cell apoptosis and inhibition of cyclooxygenase2 expression in A549 lung cancer cells. Mol Med Rep. 2014;9(2):763-767."}, {"Citation": "Burhans WC, Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res. 2007;35(22):7545-7556."}, {"Citation": "Lu T, Finkel T. Free radicals and senescence. Exp Cell Res. 2008;314(9):1918-1922."}, {"Citation": "Kim YH, Park TJ. Cellular senescence in cancer. BMB Rep. 2019;52(1):42-46."}, {"Citation": "Wang B, Kohli J, Demaria M. Senescent cells in cancer therapy: friends or foes? Trends Cancer. 2020;6(10):838-857."}, {"Citation": "Schosserer M, Grillari J, Breitenbach M. The dual role of cellular senescence in developing tumors and their response to cancer therapy. Front Oncol. 2017;7:278."}], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "11", "Day": "17"}, {"Year": "2020", "Month": "12", "Day": "6"}, {"Year": "2020", "Month": "12", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "16", "Hour": "8", "Minute": "46"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33325610", "10.1002/tox.23079"]}}]}